Latent Antigen Vaccination in a Model Gammaherpesvirus Infection
Vaccines that can reduce the load of latent gammaherpesvirus infections are eagerly sought. One attractive strategy is vaccination against latency-associated proteins, which may increase the efficiency with which T cells recognize and eliminate latently infected cells. However, due to the lack of tr...
Gorde:
| Argitaratua izan da: | J Virol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society for Microbiology (ASM)
2001
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC115072/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11483773/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.17.8283-8288.2001 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|